Skip to main content
Top

Fluoroscopy-free Transcatheter Atrial Septal Defect Closure: A Simplified Approach

Published in:

Abstract

Purpose of Review

To provide an overview of fluoroscopy-free transcatheter atrial septal defect (ASD) closure and introduce a simplified approach that avoids pulmonary vein instrumentation.

Recent Findings

Since the first reported fluoroscopy-free ASD closure 24 years ago, only a few small series have described this technique. We present a simplified and less cumbersome approach to encourage wider adoption of the fluoroscopy-free method to suitable ASD anatomy.

Results

Fluoroscopy free ASD closure was performed in 9 patients using the conventional technique (Group 1) and 23 patients using our simplified approach of direct placement of the device into the defect (Group 2). Median age and weight were 28 years, 53 kg in Group 1 (range: 5–52 years, 22–88 kg) and 36 years, 66 kg in Group 2 (range: 4–76 years, 16–115 kg). Devices were successfully implanted in all patients, with a median device size of 21 mm (Group 1: 9–36 mm, Group 2: 10–33 mm). Procedural time was 47 min for Group 1 and 35 min for Group 2 (p = 0.09). Length of hospital stay was similar in both groups. There were no acute or long-term complications and no need for reintervention.

Summary

Transcatheter ASD closure without the use of fluoroscopy using the simplified approach is safe and effective, offers a shorter procedure duration and minimises instrumentation within the left atrium and pulmonary veins. Patient selection is key and with greater experience, this procedure may be applicable to a wider selection of ASD anatomy.
Title
Fluoroscopy-free Transcatheter Atrial Septal Defect Closure: A Simplified Approach
Authors
Naychi Lwin
Piia Suursalmi
Sophia Yong
Saleha Kabir
Matthew I Jones
Alexandra Savis
Shakeel A Qureshi
Eric Rosenthal
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-024-02177-5
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

Echocardiographic Evaluation of the Post-Heart Transplant Patient

Endovascular Treatment for Aortic Diseases: Intercontinental Disparities

Eosinophilic Myocarditis: A Concise Review

  • Open Access
  • Myocarditis
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Pulmonary Embolism in Women in the Era of Expanding Advanced Therapies

  • Thrombectomy
  • Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME